ANNEXSupplementary provisions
ANNEX The entry monepantel in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Monepantel Monepantel-sulfone Ovine, caprine 700 μg/kg Muscle Not for use in animals producing milk for human consumption. Antiparasitic agents/Agents acting against endoparasites’ 7 000 μg/kg Fat 5 000 μg/kg Liver 2 000 μg/kg Kidney